Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Valeant Pharmaceuticals (VRX) Stock Price - Where Is It Headed? By KT Astrologer

|Includes: Bausch Health Companies Inc. (BHC)

Dec 15, 2016 VRX stock closed today at $13.60 which is about 94% down from its peak of about $250 set on July 2015. Lets look at where VRX stock price is headed based on Vedic Astrology.

First we need to get the natal chart for the stock. But I do not predict stock price based on the company start date or trading start date since it does not make much sense. Because the major stakeholders may keep changing after the company has founded or while making progress.

If the majority of the stock is held by a one or set of people, then it is clear to predict where the stock price is headed to! In case of VRX, if we can look into the horoscope of Bill Ackman, it is good enough to predict the stock price movement of VRX.

With respect Valeant Pharmaceuticals, Bill Ackman, founder and CEO of pershing,square, is one of the major shareholder. By looking at the chart of Bill Ackman (www.ktastro.com/article/?id=2) is good enough to predict the stock price of VRX going forward.

Bill Ackman is currently running favorable Sani Maha Dasa, that is due to give him big fortunes from Jan 20, 2017 onward. The whole year of 2017 is looking great for him. Hence he will recover his losses from Valeant Pharmaceuticals and achieve great name and fame from the people, investors in USA.
Based on his chart, VRX is expected to move up anytime in the upcoming weeks, especially from Mid Jan 2017. There is no surprise if we see VRX trading near $70 with in the next 12 months which is 500% percentage gain from the current stock price closed today at $13.60.

Disclaimer:

This article is written for educational and informational purpose only. This is not intended to provide any trading or investments advise.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.